Intervention Review

Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade

  1. Amir Abrishami1,*,
  2. Joyce Ho1,
  3. Jean Wong1,
  4. Ling Yin2,
  5. Frances Chung1

Editorial Group: Cochrane Anaesthesia Group

Published Online: 7 OCT 2009

Assessed as up-to-date: 16 AUG 2008

DOI: 10.1002/14651858.CD007362.pub2

Database Title

Additional Information

How to Cite

Abrishami A, Ho J, Wong J, Yin L, Chung F. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD007362. DOI: 10.1002/14651858.CD007362.pub2.

Author Information

  1. 1

    Toronto Western Hospital, University Health Network, University of Toronto, Department of Anesthesia, Toronto, Ontario, Canada

  2. 2

    McDougall Scientific Ltd, Department of statistics, Toronto, Ontario, Canada

*Amir Abrishami, Department of Anesthesia, Toronto Western Hospital, University Health Network, University of Toronto, 399 Bathurst Street, 2-241A McLaughlin Wing, Toronto, Ontario, M5T 2S8, Canada. amir.abrishami@uhn.on.ca.

Publication History

  1. Publication Status: New
  2. Published Online: 7 OCT 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (61K)Standard (471K)Full (573K)

  1. Current Version

    Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade

    Amir Abrishami, Joyce Ho, Jean Wong, Ling Yin and Frances Chung

    Article first published online: 7 OCT 2009 | DOI: 10.1002/14651858.CD007362.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade

    Amir Abrishami, Joyce Ho, Ling Yin, Jean Wong and Frances Chung

    Article first published online: 8 JUL 2009 | DOI: 10.1002/14651858.CD007362

View Full Article (HTML) Summary (61K)Standard (471K)Full (573K)